Small Molecule Reversible Inhibitors of Bruton's Tyrosine Kinase (BTK): Structure-Activity Relationships Leading to the Identification of 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxo-3,4-dihydroquinazolin-3-yl)phenyl]-9H-carbazole-1-carboxamide (BMS-935177)

被引：42

作者：

De Lucca, George V. ^{[1
]}

Shi, Qing ^{[1
]}

Liu, Qingjie ^{[1
]}

Batt, Douglas G. ^{[1
]}

Bertrand, Myra Beaudoin ^{[1
]}

Rampulla, Rick ^{[1
]}

Mathur, Arvind ^{[1
]}

Discenza, Lorell ^{[4
]}

D'Arienzo, Celia ^{[4
]}

Dai, Jun ^{[4
]}

Obermeier, Mary ^{[4
]}

Vickery, Rodney ^{[4
]}

Zhang, Yingru ^{[4
]}

Yang, Zheng ^{[4
]}

Marathe, Punit ^{[4
]}

Tebben, Andrew J. ^{[3
]}

Muckelbauer, Jodi K. ^{[3
]}

Chang, ChiehYing J. ^{[3
]}

Zhang, Huiping ^{[1
]}

Gillooly, Kathleen ^{[2
]}

Taylor, Tracy ^{[2
]}

Pattoli, Mark A. ^{[2
]}

Skala, Stacey ^{[2
]}

Kukral, Daniel W. ^{[5
]}

McIntyre, Kim W. ^{[2
]}

Salter-Cid, Luisa ^{[2
]}

Fura, Aberra ^{[4
]}

Burke, James R. ^{[2
]}

Banish, Joel C. ^{[1
]}

Carter, Percy H. ^{[1
]}

Tino, Joseph A. ^{[1
]}

机构：

[1] Bristol Myers Squibb Res & Dev, Immunosci Discovery Chem, POB 4000, Princeton, NJ 08543 USA

[2] Bristol Myers Squibb Res & Dev, Immunosci Discovery Biol, POB 4000, Princeton, NJ 08543 USA

[3] Bristol Myers Squibb Res & Dev, Mol Struct & Design, Mol Discovery Technol, POB 4000, Princeton, NJ 08543 USA

[4] Bristol Myers Squibb Res & Dev, Metab & Pharmacokinet Dept, Pharmaceut Candidate Optimizat, POB 4000, Princeton, NJ 08543 USA

[5] Bristol Myers Squibb Res & Dev, ECTR CTTO, Dept Imaging, POB 4000, Princeton, NJ 08543 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2016年 / 59卷 / 17期

关键词：

BIOANALYTICAL PLATFORM; RHEUMATOID-ARTHRITIS; METABOLIC STABILITY; AUTOIMMUNE-DISEASES; CELL ACTIVATION; B-CELLS; DISCOVERY; POTENT; IMMUNODEFICIENCY; MICE;

D O I：

10.1021/acs.jmedchem.6b00722

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Bruton's tyrosine,kinase (BTK) belongs to the TEC family of nonreceptor tyrosine kinases and plays a critical role in multiple cell types responsible for numerous auto-immune diseases. This article will detail the structure-activity relationships (SARs) leading to a novel second generation series of potent and, selective reversible carbazole inhibitors of BTK. With an excellent pharmacokinetic profile as well as demonstrated in vivo activity and an acceptable safety profile, 7-(2-hydroxypropan-2-yl)-4-[2-methyl-3-(4-oXo-3,4-dihydroquinazdlin-3-yl)phenyl]-9H-carbazole-1-carboxarnide 6 (BMS-935177) was selected:to advance into clinical development.

引用

页码：7915 / 7935

页数：21

共 24 条

[1] Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers
Watterson, Scott H.
De Lucca, George V.
Shi, Qing
Langevine, Charles M.
Liu, Qingjie
Batt, Douglas G.
Bertrand, Myra Beaudoin
Gong, Hua
Dai, Jun
Yip, Shiuhang
Li, Peng
Sun, Dawn
Wu, Dauh-Rurng
Wang, Chunlei
Zhang, Yingru
Traeger, Sarah C.
Pattoli, Mark A.
Skala, Stacey
Cheng, Lihong
Obermeier, Mary T.
Vickery, Rodney
Discenza, Lorell N.
D'Arienzo, Celia J.
Zhang, Yifan
Heimrich, Elizabeth
Gillooly, Kathleen M.
Taylor, Tracy L.
Pulicicchio, Claudine
McIntyre, Kim W.
Galena, Michael A.
Tebben, Andy J.
Muckelbauer, Jodi K.
Chang, ChiehYing
Rampulla, Richard
Mathur, Arvind
Salter-Cid, Luisa
Barrish, Joel C.
Carter, Percy H.
Fura, Aberra
Burke, James R.
Tino, Joseph A.
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (19) : 9173 - 9200
[2] Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent Bruton's tyrosine kinase inhibitors
Lai, Meng-zhen
Song, Pei-ran
Dou, Dou
Diao, Yan-yan
Tong, Lin-jiang
Zhang, Tao
Xie, Hua
Li, Hong-lin
Ding, Jian
ACTA PHARMACOLOGICA SINICA, 2020, 41 (03) : 415 - 422
[3] Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent Bruton’s tyrosine kinase inhibitors
Meng-zhen Lai
Pei-ran Song
Dou Dou
Yan-yan Diao
Lin-jiang Tong
Tao Zhang
Hua Xie
Hong-lin Li
Jian Ding
Acta Pharmacologica Sinica, 2020, 41 : 415 - 422
[4] Design, Synthesis, and Structure-Activity Relationships of Novel 1-(Substituted)-2-Methyl-3-(4-Oxo-2-Methylquinazolin-3(4H)-yl) Isothioureas for Their Anti-HIV and Antibacterial Activities
Alagarsamy, V
Sulthana, M. T.
Chitra, K.
Solomon, V. Raja
Saravanan, G.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (03) : 548 - 556
[5] Synthesis,Crystal Structure and Anticoagulant Activity of 5-Chloro-N-[[(5S)-2-oxo-3-[4-(2-oxopyridin-1(2H)-yl)phenyl]oxazolidin-5-yl]methyl]thiophene-2-carboxamide
刘巍
袁静
张士俊
徐为人
黄长江
汤立达
结构化学, 2014, 33 (07) : 1091 - 1095
[6] Improving the Pharmacokinetic and CYP Inhibition Profiles of Azaxanthene-Based Glucocorticoid Receptor Modulators-Identification of (S)-5-(2-(9-Fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341)
Yang, Michael G.
Dhar, T. G. Murali
Xiao, Zili
Xiao, Hai-Yun
Duan, James J. -W.
Jiang, Bin
Galella, Michael A.
Cunningham, Mark
Wang, Jinhong
Habte, Sium
Shuster, David
McIntyre, Kim W.
Carman, Julie
Holloway, Deborah A.
Somerville, John E.
Nadler, Steven G.
Salter-Cid, Luisa
Barrish, Joel C.
Weinstein, David S.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (10) : 4278 - 4290
[7] A novel class of sodium/calcium exchanger inhibitors:: Design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivatives
Hasegawa, H
Muraoka, M
Matsui, K
Kojima, A
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 727 - 730
[8] Discovery of (R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153):: A potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and efficient intranasal exposure
Degnan, Andrew P.
Chaturvedula, Prasad V.
Conway, Charles M.
Cook, Deborah A.
Davis, Carl D.
Denton, Rex
Han, Xiaojun
Macci, Robert
Mathias, Neil R.
Moench, Paul
Pin, Sokhoin S.
Ren, Shelly X.
Schartman, Richard
Signor, Laura J.
Thalody, George
Widmann, Kimberly A.
Xu, Cen
Macor, John E.
Dubowchik, Gene M.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) : 4858 - 4861
[9] Synthesis, Crystal Structure and Anticoagulant Activity of 5-Chloro-N-[[(5S)-2-oxo-3-[4-(2-oxopyridin-1(2H)-yl)phenyl]oxazolidin-5-ylimethyllthiophene-2-carboxamide
Liu Wei
Yuan Jing
Zhang Shi-Jun
Xu Wei-Ren
Huang Chang-Jiang
Tang Li-Da
CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2014, 33 (07) : 1091 - 1095
[10] HIV-1 attachment inhibitors: Structure-activity relationships leading to the identification of 1-(4-benzoylpiperazin-1-yl)-2-(4-fluoro-7-(1H-1,2,3-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione
Regueiro-Ren, Alicia
Xue, Qiufen M.
Ueda, Yasutsugu
Yamanaka, Gregory
Swidorski, Jacob J.
Chen, Chung-Pin
Wang, Tao
Gong, Yi-Fei
Mathew, Marina
Parker, Dawn D.
Yang, Zheng
Eggers, Betsy
Darienzo, Celia
Malinowski, Jacek
Zheng, Ming
Lin, Pin-Fang
Meanwell, Nicholas A.
Kadow, John F.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238

← 1 2 3 →